Abstract

Central obesity has emerged as a pervasive global concern in recent times. The metabolic and cardiovascular risks associated with central obesity are not as well understood as the risks associated with obesity itself. The aim of the study is to evaluate how central obesity affects the severity of acute pancreatitis (AP). The current research included individuals aged 18 and above who were admitted for the first time to the Gastroenterology Clinic at Fırat University Hospital with a diagnosis of AP during the years 2022 and 2023. Participants were categorized into two groups based on the presence or absence of central obesity, as defined by the World Health Organization (WHO) standards. A comparative analysis was conducted among these groups, concentrating on anthropometric measurements, the Atlanta classification, Ranson score, Charlson Comorbidity Index (CCI), laboratory findings, and clinical outcomes. Patients with a Ranson score of 3 or lower were identified as having mild AP, whereas those with a score exceeding 3 were categorized as having severe AP. Out of the 75 patients who participated in the study, 45 individuals, accounting for 60%, showed signs of central obesity. In the central obesity group, the AP severity was found to be significantly higher according to Ranson scores and the Atlanta classification (p

Key words: Central obesity, acute pancreatitis, atlanta classification, ranson score